title: Rheos Baroreflex Hypertension Therapy System to treat resistant hypertension.
abstract: Resistant hypertension has a high prevalence and is associated with high morbidity and mortality. The Rheos Baroreflex Hypertension Therapy System is an implantable device that offers a completely new approach to treating patients with resistant hypertension by electrically activating the carotid baroreflex. Preliminary results from current feasibility clinical trials have shown sustained decreases in blood pressure after 1 year. The pivotal trial for US FDA approval and market release is currently ongoing. This article profiles the Rheos System and evaluates the treatment of resistant hypertension in general.
authors: University Hospital Maastricht, Maastricht, The Netherlands. ingrid.scheffers@intmed.unimaas.nl
authors: Ingrid J M
authors: IJ
authors: Scheffers
authors: Abraham A
authors: AA
authors: Kroon
authors: Jan H M
authors: JH
authors: Tordoir
authors: Peter W
authors: PW
authors: de Leeuw
mesh_terms: D000818:Animals; D017704:Baroreflex / Q000502:physiology*; D019917:Blood Vessel Prosthesis Implantation / Q000191:economics / Q000295:instrumentation*; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D005240:Feasibility Studies; D006801:Humans; D006973:Hypertension / Q000503:physiopathology* / Q000628:therapy*